Showing results (441-450 of 476) with videos related to

Sort By:
Pageof 48
MMWR. Morbidity and Mortality Weekly Report|February 27, 2025
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025Ruth Link-Gelles, Sean Chickery, Alexander Webber, et al.
MMWR. Morbidity and Mortality Weekly Report|October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022Diya Surie, Levi Bonnell, Katherine Adams, et al.
The New England Journal of Medicine|October 5, 2020
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis, David R Flum, Giana H Davidson, et al.
JAMA Network Open|July 7, 2022
Analysis of Outcomes Associated With Outpatient Management of Nonoperatively Treated Patients With Appendicitis, David A Talan, Gregory J Moran, et al.
MMWR. Morbidity and Mortality Weekly Report|October 5, 2023
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023Diya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Nature Communications|July 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccinesLi Wang, Markus H Kainulainen, Nannan Jiang, et al.
Vaccine|November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United StatesCaitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
The Journal of Infectious Diseases|April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsJennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
Pageof 48